rs713993043
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001376.5(DYNC1H1):c.791G>A(p.Arg264Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R264G) has been classified as Pathogenic.
Frequency
Consequence
NM_001376.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25609763, 26100331, 25512093, 32656949) -
- -
- -
- -
Charcot-Marie-Tooth disease axonal type 2O Pathogenic:1Uncertain:1
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 264 of the DYNC1H1 protein (p.Arg264Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with spinal muscular atrophy (PMID: 25609763). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 210883). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DYNC1H1 protein function. This variant disrupts the p.Arg264 amino acid residue in DYNC1H1. Other variant(s) that disrupt this residue have been observed in individuals with DYNC1H1-related conditions (PMID: 25512093), which suggests that this may be a clinically significant amino acid residue. -
- -
Neurodevelopmental delay Pathogenic:1
- -
DYNC1H1-related neurological disorders Pathogenic:1
The DYNC1H1 c.791G>A, p.(Arg264Gln) missense variant has been identified in an individual with a phenotype consistent with DYNC1H1-related neurological disorders who demonstrated lower limb malformations, compromised hand function, fine motor difficulties and a brain malformation resembling polymicrogyria by MRI (Scoto et al. 2015). Additionally, a different amino acid substitution at the same codon, p.(Arg264Leu), has been reported in an individual with a phenotype consistent with DYNC1H1-related neurological disorders (Peeters et al. 2015). This variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Multiple lines of computational evidence suggest this variant may impact the gene or gene product. The variant was identified in a de novo state in the proband. Based on the available evidence, the c.791G>A, p.(Arg264Gln) variant is classified as likely pathogenic for DYNC1H1-related neurological disorders. -
not specified Uncertain:1
- -
Neuronopathy, distal hereditary motor, autosomal dominant Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at